Conflict of Interest Form from Disruption of in vivo Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study

MLA

Adrian Wiestner, et al. Conflict of Interest Form from Disruption of in Vivo Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....486947f1dc33c3bb655af4f909a88173&authtype=sso&custid=ns315887.

APA

Adrian Wiestner, Mohammed Z.H. Farooqui, Gerald E. Marti, Clare Sun, Jade Jones, Deanna H. Wong, Yuh Shan Lee, Janet Valdez, Raul C. Braylan, Katherine R. Calvo, Constance M. Yuan, Maryalice Stetler-Stevenson, Sabrina Martyr, Betty Y. Chang, Angelique Biancotto, Julio Gomez-Rodriguez, Irina Maric, Sarah E.M. Herman, & Carsten U. Niemann. (2023). Conflict of Interest Form from Disruption of in vivo Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study.

Chicago

Adrian Wiestner, Mohammed Z.H. Farooqui, Gerald E. Marti, Clare Sun, Jade Jones, Deanna H. Wong, Yuh Shan Lee, et al. 2023. “Conflict of Interest Form from Disruption of in Vivo Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....486947f1dc33c3bb655af4f909a88173&authtype=sso&custid=ns315887.